About this book
The American Anti-Vivisection Society (AAVS) petitioned the National Institutes of Health (NIH) on April 23, 1997, to prohibit the use of animals in the production of mAb. On September 18, 1997, NIH declined to prohibit the use of mice in mAb production, stating that "e;the ascites method of mAb production is scientifically appropriate for some research projects and cannot be replaced."e; On March 26, 1998, AAVS submitted a second petition, stating that "e;NIH failed to provide valid scientific reasons for not supporting a proposed ban."e; The office of the NIH director asked the National Research Council to conduct a study of methods of producing mAb.In response to that request, the Research Council appointed the Committee on Methods of Producing Monoclonal Antibodies, to act on behalf of the Institute for Laboratory Animal Research of the Commission on Life Sciences, to conduct the study. The 11 expert members of the committee had extensive experience in biomedical research, laboratory animal medicine, animal welfare, pain research, and patient advocacy (Appendix B). The committee was asked to determine whether there was a scientific necessity for the mouse ascites method; if so, whether the method caused pain or distress; and, if so, what could be done to minimize the pain or distress. The committee was also asked to comment on available in vitro methods; to suggest what acceptable scientific rationale, if any, there was for using the mouse ascites method; and to identify regulatory requirements for the continued use of the mouse ascites method.The committee held an open data-gathering meeting during which its members summarized data bearing on those questions. A 1-day workshop (Appendix A) was attended by 34 participants, 14 of whom made formal presentations. A second meeting was held to finalize the report. The present report was written on the basis of information in the literature and information presented at the meeting and the workshop.
Frequently asked questions
- Essential is ideal for learners and professionals who enjoy exploring a wide range of subjects. Access the Essential Library with 800,000+ trusted titles and best-sellers across business, personal growth, and the humanities. Includes unlimited reading time and Standard Read Aloud voice.
- Complete: Perfect for advanced learners and researchers needing full, unrestricted access. Unlock 1.4M+ books across hundreds of subjects, including academic and specialized titles. The Complete Plan also includes advanced features like Premium Read Aloud and Research Assistant.
Please note we cannot support devices running on iOS 13 and Android 7 or earlier. Learn more about using the app.
Information
Table of contents
- Front Matter
- Preface
- Contents
- Executive Summary
- Introduction
- 1 Generation of Hybridomas: Permanent Cell Lines Secreting Monoclonal Antibodies
- 2 In Vitro Production of Monoclonal Antibody
- 3 Scientific Needs for Mouse Ascites Production of mAb
- 4 Summary of Advantages and Disadvantages of In Vitro and In Vivo Methods
- 5 Large-Scale Production of Monoclonal Antibodies
- 6 Animal-Welfare Issues Related to the Ascites Method for Producing Monoclonal Antibodies
- 7 Conclusions and Recommendations
- References
- APPENDIX A Workshop on Methods of Producing Monoclonal Antibodies
- APPENDIX B Biographical Sketches of Authoring Committee